Will Cao

Will is the co-founder and CEO of Pando Bioscience. Pando is an AI-driven synthetic biology company revolutionizing enzyme engineering for the pharmaceutical manufacturing and life science tools. Our ultra-high-throughput screening platform screens 1000-fold more enzymes 75% faster and 80% cheaper than traditional methods. This empowers our AI models to efficiently optimize enzymes across multiple properties, delivering high-performing, industrial-grade enzymes that create and capture new market value.